Ironwood Pharma (IRWD) Misses Q4 EPS by 8c

Ironwood Pharma (NASDAQ: IRWD) reported Q4 EPS of $0.27, $0.08 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $117.13 million versus the consensus estimate of $109.87 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Stifel Starts Victrex Plc. (VCT:LN) (VTXPF) at Buy
• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates